OCULAR HYPERTENSION (OH)
Clinical trials for OCULAR HYPERTENSION (OH) explained in plain language.
Never miss a new study
Get alerted when new OCULAR HYPERTENSION (OH) trials appear
Sign up with your email to follow new studies for OCULAR HYPERTENSION (OH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Preservative-Free eye drop could match leading glaucoma treatment
Disease control Recruiting nowThis phase 3 trial tests whether a preservative-free version of bimatoprost eye drops works as well as the standard Lumigan drops for lowering eye pressure. About 600 adults with primary open-angle glaucoma or ocular hypertension in both eyes will receive either the new formulati…
Matched conditions: OCULAR HYPERTENSION (OH)
Phase: PHASE3 • Sponsor: YS Life Science Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New tool for glaucoma implant: easier placement?
Disease control Recruiting nowThis study tests a redesigned inserter for the travoprost implant, a tiny device placed inside the eye to lower pressure in people with open-angle glaucoma or ocular hypertension. About 30 adults will receive the implant using the updated inserter. The main goal is to see if doct…
Matched conditions: OCULAR HYPERTENSION (OH)
Sponsor: Glaukos Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC